Connor P Oates1, Manjula Ananthram1, Stephen S Gottlieb2. 1. School of Medicine, University of Maryland, Baltimore, MD, USA. 2. School of Medicine, University of Maryland, Baltimore, MD, USA. sgottlie@medicine.umaryland.edu.
Abstract
PURPOSE OF REVIEW: This paper reviews treatment options for sleep disordered breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with the best evidence for long-term use in patients with heart failure and to minimize uncertainties in clinical practice by examining frequently discussed questions: what is the role of continuous positive airway pressure (CPAP) in patients with heart failure? Is adaptive servo-ventilation (ASV) safe in patients with heart failure? To what extent is SDB a modifiable risk factor? RECENT FINDINGS: Consistent evidence has demonstrated that the development of SDB in patients with heart failure is a poor prognostic indicator and a risk factor for cardiovascular mortality. However, despite numerous available interventions for obstructive sleep apnea and central sleep apnea, it remains unclear what effect these therapies have on patients with heart failure. To date, all major randomized clinical trials have failed to demonstrate a survival benefit with SDB therapy and one major study investigating the use of adaptive servo-ventilation demonstrated harm. Significant questions persist regarding the management of SDB in patients with heart failure. Until appropriately powered trials identify a treatment modality that increases cardiovascular survival in patients with SDB and heart failure, a patient's heart failure management should remain the priority of medical care.
PURPOSE OF REVIEW: This paper reviews treatment options for sleep disordered breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with the best evidence for long-term use in patients with heart failure and to minimize uncertainties in clinical practice by examining frequently discussed questions: what is the role of continuous positive airway pressure (CPAP) in patients with heart failure? Is adaptive servo-ventilation (ASV) safe in patients with heart failure? To what extent is SDB a modifiable risk factor? RECENT FINDINGS: Consistent evidence has demonstrated that the development of SDB in patients with heart failure is a poor prognostic indicator and a risk factor for cardiovascular mortality. However, despite numerous available interventions for obstructive sleep apnea and central sleep apnea, it remains unclear what effect these therapies have on patients with heart failure. To date, all major randomized clinical trials have failed to demonstrate a survival benefit with SDB therapy and one major study investigating the use of adaptive servo-ventilation demonstrated harm. Significant questions persist regarding the management of SDB in patients with heart failure. Until appropriately powered trials identify a treatment modality that increases cardiovascular survival in patients with SDB and heart failure, a patient's heart failure management should remain the priority of medical care.
Entities:
Keywords:
ASV; Central sleep apnea; Heart failure; Obstructive sleep apnea; Treatment of sleep disordered breathing
Authors: P A Lanfranchi; A Braghiroli; E Bosimini; G Mazzuero; R Colombo; C F Donner; P Giannuzzi Journal: Circulation Date: 1999-03-23 Impact factor: 29.690
Authors: Christine Eulenburg; Karl Wegscheider; Holger Woehrle; Christiane Angermann; Marie-Pia d'Ortho; Erland Erdmann; Patrick Levy; Anita K Simonds; Virend K Somers; Faiez Zannad; Helmut Teschler; Martin R Cowie Journal: Lancet Respir Med Date: 2016-08-31 Impact factor: 30.700
Authors: Rami Khayat; Roy Small; Lisa Rathman; Steven Krueger; Becky Gocke; Linda Clark; Laura Yamokoski; William T Abraham Journal: J Card Fail Date: 2013-06 Impact factor: 5.712
Authors: Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley Journal: J Am Coll Cardiol Date: 2007-04-02 Impact factor: 24.094
Authors: Owen D Lyons; John S Floras; Alexander G Logan; Robert Beanlands; Joaquin Durán Cantolla; Michael Fitzpatrick; John Fleetham; R John Kimoff; Richard S T Leung; Geraldo Lorenzi Filho; Pierre Mayer; Lisa Mielniczuk; Debra L Morrison; Clodagh M Ryan; Frederic Series; George A Tomlinson; Anna Woo; Michael Arzt; Sairam Parthasarathy; Stefania Redolfi; Takatoshi Kasai; Gianfranco Parati; Diego H Delgado; T Douglas Bradley Journal: Eur J Heart Fail Date: 2017-04 Impact factor: 15.534
Authors: C M Ryan; J S Floras; A G Logan; R J Kimoff; F Series; D Morrison; K A Ferguson; I Belenkie; M Pfeifer; J Fleetham; P J Hanly; M Smilovitch; M Arzt; T D Bradley Journal: Eur Respir J Date: 2010-03 Impact factor: 16.671
Authors: Olaf Oldenburg; Thomas Bitter; Marcus Wiemer; Christoph Langer; Dieter Horstkotte; Cornelia Piper Journal: Sleep Med Date: 2009-01-08 Impact factor: 3.492
Authors: Corrado Pelaia; Giuseppe Armentaro; Mara Volpentesta; Luana Mancuso; Sofia Miceli; Benedetto Caroleo; Maria Perticone; Raffaele Maio; Franco Arturi; Egidio Imbalzano; Francesco Andreozzi; Francesco Perticone; Giorgio Sesti; Angela Sciacqua Journal: Front Cardiovasc Med Date: 2022-04-05